267 related articles for article (PubMed ID: 3890786)
41. Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin.
Coltman CA; Bodey GP; Hewlett JS; Haut A; Bickers J; Balcerzak SP; Costanzi JJ; Freireich EJ; McCredie KB; Groppe C; Smith TL; Gehan EA
Arch Intern Med; 1978 Sep; 138(9):1342-8. PubMed ID: 686922
[TBL] [Abstract][Full Text] [Related]
42. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Vogler WR; Winton EF; Gordon DS; Raney MR; Go B; Meyer L
Blood; 1984 May; 63(5):1039-45. PubMed ID: 6201211
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group].
Yanai M; Tsuji Y; Takeda T; Oka T; Yatabe M; Kikuta A; Kaneko Y; Sekine I; Matsushita T; Utsumi J
Rinsho Ketsueki; 1987 Oct; 28(10):1754-62. PubMed ID: 3330737
[No Abstract] [Full Text] [Related]
44. Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine.
Cervantes F; Rozman C; Bladé J; Montserrat E; Grañena A
Cancer Treat Rep; 1985; 69(7-8):923-4. PubMed ID: 3860299
[No Abstract] [Full Text] [Related]
45. [Treatment of acute leukemia in adults by the OAP regimen].
Agafonov VA; Kott TL; Kovaleva LG; Volkova MA; Faĭnshteĭn FE
Klin Med (Mosk); 1976 Aug; 54(8):37-42. PubMed ID: 1070564
[No Abstract] [Full Text] [Related]
46. Remission maintenance therapy in acute myelogenous leukemia.
Embury SH; Elias L; Heller PH; Hood CE; Greenberg PL; Schrier SL
West J Med; 1977 Apr; 126(4):267-72. PubMed ID: 266313
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.
Jones SE; Grozea PN; Miller TP; Van Slyck EJ; Balcerzak SP; Costanzi JJ; Morrison FS; Eyre HJ; Fabian CJ; Dabich L
J Clin Oncol; 1985 Oct; 3(10):1318-24. PubMed ID: 3900301
[TBL] [Abstract][Full Text] [Related]
48. Long-term survival in acute leukemia. Twenty-two adult patients surviving for over five years.
Evensen SA; Stavem P
Acta Med Scand; 1986; 219(1):79-83. PubMed ID: 3456695
[TBL] [Abstract][Full Text] [Related]
49. Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy.
Omura GA; Vogler WR; Lefante J; Silberman H; Knospe W; Gordon D; Jarrell R
Cancer; 1982 Apr; 49(8):1530-6. PubMed ID: 7039813
[TBL] [Abstract][Full Text] [Related]
50. Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisolone.
Uzuka Y; Saito Y
Cancer Treat Rep; 1985 Nov; 69(11):1297-9. PubMed ID: 3867403
[TBL] [Abstract][Full Text] [Related]
51. A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia.
Keating MJ; Smith TL; McCredie KB; Bodey GP; Hersh EM; Gutterman JU; Gehan E; Freireich EJ
Cancer; 1981 Jun; 47(12):2779-88. PubMed ID: 6942906
[TBL] [Abstract][Full Text] [Related]
52. [A study of B-triple V (behenoyl-ara C, etoposide, vincristine, vinblastine) in acute leukemia].
Kohsaki M; Nagai K; Kanamaru A; Takaku F; Kobayashi Y; Mizoguchi H; Akaboshi M; Tsuchiya J; Miyawaki S; Sawamura M
Rinsho Ketsueki; 1988 Apr; 29(4):527-33. PubMed ID: 3043041
[No Abstract] [Full Text] [Related]
53. [Evaluation of the myelogram carried out on the 6th day of remission- inducing treatment of acute nonlymphoblastic leukemia in adults as an indicator of therapeutic effectiveness].
Kniewska I; Hołowiecki J; Krykowski E; Rudzka E; Krzemień S; Krawczyk M; Duraj M; Brodowski L; Urbańska-Ryś H
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):872-4. PubMed ID: 2487940
[TBL] [Abstract][Full Text] [Related]
54. [Treatment of acute lymphoblastic leukemia in adults using the 08 LA 74 and RALL 81 A protocols].
Colović M; Petrović M; Janković G; Janosević S; Jancić M
Srp Arh Celok Lek; 1988 Mar; 116(3):227-33. PubMed ID: 3166210
[No Abstract] [Full Text] [Related]
55. Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival.
Sauter C; Berchtold W; Fopp M; Gratwohl A; Imbach P; Maurice P; Tschopp L; von Fliedner V; Cavalli F
Lancet; 1984 Feb; 1(8373):379-82. PubMed ID: 6141436
[TBL] [Abstract][Full Text] [Related]
56. Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia.
Riccardi A; Invernizzi R; Girino M; Cassano E; Giordano M; Ucci G; Danova M; Montecucco C; Bobbio-Pallavicini E; Ascari E
Haematologica; 1986; 71(2):129-33. PubMed ID: 3087833
[No Abstract] [Full Text] [Related]
57. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
[TBL] [Abstract][Full Text] [Related]
58. Long term follow-up of remission patients in adult acute leukemia.
Gerecke D; Kress M; Hirschmann WD
Klin Wochenschr; 1983 Oct; 61(19):963-7. PubMed ID: 6580502
[TBL] [Abstract][Full Text] [Related]
59. [Effectiveness of low dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes--analysis of factors influencing the duration of responses, survival and clinical effects].
Sawada H; Abe T; Akasaka K; Ishikura H; Izumi Y; Inamoto Y; Usui T; Okazaki T; Okada H; Katoh Y
Rinsho Ketsueki; 1987 Sep; 28(9):1553-60. PubMed ID: 3437517
[No Abstract] [Full Text] [Related]
60. Chemoimmunotherapy of adult acute leukemia.
McCredie KB; Bodey GP; Freireich EJ; Hester JP; Rodriguez V; Keating MJ
Cancer; 1981 Mar; 47(6):1256-61. PubMed ID: 6939477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
